Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May 29;25(11):5921.
doi: 10.3390/ijms25115921.

Pathogenesis of Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome: A Case Report and Review of the Literature

Affiliations
Review

Pathogenesis of Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome: A Case Report and Review of the Literature

Chiara Gioia et al. Int J Mol Sci. .

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening condition characterized by the uncontrolled activation of cytotoxic T lymphocytes, NK cells, and macrophages, resulting in an overproduction of pro-inflammatory cytokines. A primary and a secondary form are distinguished depending on whether or not it is associated with hematologic, infectious, or immune-mediated disease. Clinical manifestations include fever, splenomegaly, neurological changes, coagulopathy, hepatic dysfunction, cytopenia, hypertriglyceridemia, hyperferritinemia, and hemophagocytosis. In adults, therapy, although aggressive, is often unsuccessful. We report the case of a 41-year-old man with no apparent history of previous disease and an acute onset characterized by fever, fatigue, and weight loss. The man was from Burkina Faso and had made trips to his home country in the previous five months. On admission, leukopenia, thrombocytopenia, increased creatinine and transaminases, LDH, and CRP with a normal ESR were found. The patient also presented with hypertriglyceridemia and hyperferritinemia. An infectious or autoimmune etiology was ruled out. A total body CT scan showed bilateral pleural effusion and hilar mesenterial, abdominal, and paratracheal lymphadenopathy. Lymphoproliferative disease with HLH complication was therefore suspected. High doses of glucocorticoids were then administered. A cytologic analysis of the pleural effusion showed anaplastic lymphoma cells and bone marrow aspirate showed hemophagocytosis. An Epstein-Barr Virus (EBV) DNA load of more than 90000 copies/mL was found. Bone marrow biopsy showed a marrow localization of peripheral T lymphoma. The course was rapidly progressive until the patient died. HLH is a rare but usually fatal complication in adults of hematologic, autoimmune, and malignant diseases. Very early diagnosis and treatment are critical but not always sufficient to save patients.

Keywords: T lymphoma; hemophagocytic lymphohistiocytosis; macrophage activation syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Chest and abdomen CT. (A,B) show mediastinal adenopathy and bilateral pleural effusion with ground glass parenchymal thickening, in chest CT. (C) displays nodular thickenings in paraortocaval and retrocaval areas, in abdomen CT.
Figure 2
Figure 2
Bone marrow trephine biopsy. At low magnification (A) there is evident marrow hypoplasia, associated with atrophy of fat cells. At higher magnification (B) all hematopoietic lineages seem reduced, with marked dysmyelopoiesis and only relative sparing of some erythropoietic islands in the lower quadrants. No figures of hemophagocytosis could be recognized (Hematoxylin and eosin; original magnification: (A)—4×; (B)—20×).

References

    1. Chandrakasan S., Filipovich A.H. Hemophagocytic lymphohistiocytosis: Advances in pathophysiology, diagnosis, and treatment. J. Pediatr. 2013;163:1253–1259. doi: 10.1016/j.jpeds.2013.06.053. - DOI - PubMed
    1. Al-Samkari H., Berliner N. Hemophagocytic Lymphohistiocytosis. Annu. Rev. Pathol. 2018;24:27–49. doi: 10.1146/annurev-pathol-020117-043625. - DOI - PubMed
    1. Fajgenbaum D.C., June C.H. Cytokine Storm. N. Engl. J. Med. 2020;383:2255–2273. doi: 10.1056/NEJMra2026131. - DOI - PMC - PubMed
    1. Henderson L.A., Canna S.W., Schulert G.S., Volpi S., Lee P.Y., Kernan K.F., Caricchio R., Mahmud S., Hazen M.M., Halyabar O., et al. On the Alert for Cytokine Storm: Immunopathology in COVID-19. Arthritis Rheumatol. 2020;72:1059–1063. doi: 10.1002/art.41285. - DOI - PMC - PubMed
    1. Smith M.C., Cohen D.N., Greig B., Yenamandra A., Vnencak-Jones C., Thompson M.A., Kim A.S. The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder. Int. J. Clin. Exp. Pathol. 2014;7:5738–5749. - PMC - PubMed

MeSH terms